Progyny (NASDAQ:PGNY) Updates Q4 Earnings Guidance

Progyny (NASDAQ:PGNY) issued an update on its fourth quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.07-0.10 for the period, compared to the consensus EPS estimate of $0.14. The company issued revenue guidance of $266.2-281.2 million, compared to the consensus revenue estimate of $292.69 million.

Progyny Stock Performance

Shares of PGNY traded up $0.12 during trading hours on Tuesday, hitting $17.18. 1,979,516 shares of the company were exchanged, compared to its average volume of 1,371,510. The company has a market cap of $1.55 billion, a PE ratio of 27.27, a PEG ratio of 1.57 and a beta of 1.44. Progyny has a 52 week low of $13.93 and a 52 week high of $42.08. The firm’s 50 day moving average is $18.01 and its 200-day moving average is $23.73.

Analyst Ratings Changes

Several brokerages have recently commented on PGNY. Canaccord Genuity Group decreased their target price on Progyny from $24.00 to $18.00 and set a “hold” rating on the stock in a report on Friday, September 20th. Jefferies Financial Group cut their price target on shares of Progyny from $31.00 to $24.00 and set a “buy” rating for the company in a research note on Thursday, September 19th. Leerink Partnrs downgraded Progyny from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 7th. Leerink Partners lowered their price target on Progyny from $25.00 to $21.00 and set a “market perform” rating for the company in a report on Thursday, September 19th. Finally, BTIG Research cut shares of Progyny from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 7th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $27.73.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.